Normal view MARC view ISBD view

Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. [Review]

MedStar author(s):

Citation: Trends in Cardiovascular Medicine. 2020 May 28PMID: 32474135Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2020 ISSN:

1050-1738

Name of journal: Trends in cardiovascular medicineAbstract: Patients with pre-existing cardiovascular disease and risk factors are more likely to experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID-19). Additionally, consistent reports of cardiac injury and de novo cardiac complications, including possible myocarditis, arrhythmia, and heart failure in patients without prior cardiovascular disease or significant risk factors, are emerging, possibly due to an accentuated host immune response and cytokine release syndrome. As the spread of the virus increases exponentially, many patients will require medical care either for COVID-19 related or traditional cardiovascular issues. While the COVID-19 pandemic is dominating the attention of the healthcare system, there is an unmet need for a standardized approach to deal with COVID-19 associated and other traditional cardiovascular issues during this period. We provide consensus guidance for the management of various cardiovascular conditions during the ongoing COVID-19 pandemic with the goal of providing the best care to all patients and minimizing the risk of exposure to frontline healthcare workers. Copyright (c) 2020. Published by Elsevier Inc.All authors: Asnani A, Bang V, Barac A, Brar S, Dani SS, Fradley M, Ganatra S, Guha A, Gupta D, Hayek SS, Herrmann J, Ky B, Leja M, Lenihan D, Mascari P, Neilan TG, Nohria A, Parikh R, Patel R, Patten RD, Resnic FS, Shah S, Shreyder K, Singh A, Thavendiranathan P, Venesy DMFiscal year: FY2020Digital Object Identifier:

https://dx.doi.org/10.1016/j.tcm.2020.05.004

Date added to catalog: 2020-08-26

Holdings ( 1 )
Title notes ( 2 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	32474135	Available		32474135

Patients with pre-existing cardiovascular disease and risk factors are more likely to experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID-19). Additionally, consistent reports of cardiac injury and de novo cardiac complications, including possible myocarditis, arrhythmia, and heart failure in patients without prior cardiovascular disease or significant risk factors, are emerging, possibly due to an accentuated host immune response and cytokine release syndrome. As the spread of the virus increases exponentially, many patients will require medical care either for COVID-19 related or traditional cardiovascular issues. While the COVID-19 pandemic is dominating the attention of the healthcare system, there is an unmet need for a standardized approach to deal with COVID-19 associated and other traditional cardiovascular issues during this period. We provide consensus guidance for the management of various cardiovascular conditions during the ongoing COVID-19 pandemic with the goal of providing the best care to all patients and minimizing the risk of exposure to frontline healthcare workers. Copyright (c) 2020. Published by Elsevier Inc.

English